Accsl is one of the genes identified as a hub gene, closely related to the occurrence and development of diffuse large B-cell lymphoma (DLBCL). Through gene expression and network perturbation analysis of DLBCL patients at different clinical stages, it was found to be among the key genes associated with this disease [1].

In the research on DLBCL, gene-expression-based analysis including differential expression gene identification, weighted gene correlation network analysis (WGCNA), and key driver analysis led to the discovery of Accsl as a hub gene. This indicates its potential importance in the biological processes related to DLBCL progression, such as those related to the NOD-like receptor signaling pathway, neutrophil activation, secretory granule membrane, and carboxylic acid binding [1].

In conclusion, Accsl appears to play a significant role in the development of DLBCL. The identification of Accsl as a hub gene through gene-expression-based network analysis provides insights into the biological mechanisms of DLBCL, which may contribute to the discovery of new treatment strategies for this disease.

References:

1. Xiang, Chenxi, Ni, Huimin, Wang, Zhina, Ma, Dongshen, Liu, Hui. 2021. Agent Repurposing for the Treatment of Advanced Stage Diffuse Large B-Cell Lymphoma Based on Gene Expression and Network Perturbation Analysis. In Frontiers in genetics, 12, 756784. doi:10.3389/fgene.2021.756784. https://pubmed.ncbi.nlm.nih.gov/34721544/